Background & aims An estimated 38% of adults worldwide have non-alcoholic fatty liver
disease (NAFLD). From individual impacts to widespread public health and economic …

Conclusions: This consensus-driven multidisciplinary fatty liver disease action agenda
developed by care providers, clinical researchers, and public health and policy experts …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet
largely underappreciated liver condition which is closely associated with obesity and …

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …

Background Non‐alcoholic fatty liver disease (NAFLD) is a highly prevalent condition that
requires a comprehensive and coordinated response across sectors and disciplines. Aims In …

The Asia Pacific region is the most diverse and the most populous region in the world.
Recent socioeconomic changes have resulted in an emerging epidemic of non …

An international panel recently proposed an update to the terminology and diagnostic
criteria for fatty liver disease. The experts proposed a change in the nomenclature from non …

In evolutionary terms, nonalcoholic fatty liver disease (NAFLD) is a relatively new disease.
With a long natural history that is impacted by an individual's wider metabolic comorbidities …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a growing public health
problem worldwide and has become an important field of biomedical inquiry. We aimed to …